Cambridge Cognition Holdings plc announced that, due to a serious medical condition, Nick Kerton, Chief Executive Officer, will be taking an extended leave of absence from the company. In Nick's absence, Steven Powell, who has been head of European Operations for the past year, has been appointed Group Chief Operating Officer and will assume the responsibilities of Chief Executive Officer as an interim measure. Steven will join the Board of Directors effective July 6, 2015.

Steven Powell has over 25 years of operational and investment experience in the pharmaceutical and life sciences sector in research and development, commercial and general management roles. At the company he has been responsible for building and executing the product development pipeline and establishing the healthcare business unit as well as leading the European operational team.